Needham & Company Reiterates a 'Buy' on Ceradyne (CRDN); Q3 Results Miss Street Expectations, Bookings, Backlog Solid
Tweet Send to a Friend
Needham & Company reiterates a 'Buy' on Ceradyne, Inc. (Nasdaq: CRDN), raises PT from $27 to $28.
Needham analyst says ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Needham analyst says ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
